ARA-290

Service Description

Sky Health Wellness Clinic in Las Vegas offers ARA-290 peptide therapy, a novel investigational peptide designed to reduce inflammation, protect nerve tissue, and improve recovery in chronic and systemic conditions. ARA-290, also known as cibinetide, is a synthetic peptide derived from erythropoietin (EPO) but engineered to deliver anti-inflammatory and tissue-protective benefits without stimulating red blood cell production. This makes ARA-290 unique compared to other peptides and biologics, as it selectively activates the innate repair receptor (IRR), a pathway involved in cellular healing and modulation of inflammatory responses. By avoiding the hematopoietic effects of traditional EPO, ARA-290 can be administered safely for longer periods with reduced risk of side effects. How ARA-290 Works ARA-290 binds to and activates the innate repair receptor, a receptor system expressed on stressed or injured tissues. This activation triggers anti-inflammatory signaling, supports microvascular blood flow, reduces tissue injury, and protects nerve cells from degeneration. Research suggests it may also improve small fiber nerve function and autonomic regulation. Key Benefits of ARA-290 Therapy • Reduces systemic inflammation • Protects nerve cells from damage • Supports small fiber nerve repair • Improves pain sensitivity and autonomic symptoms in some studies • Enhances vascular repair and circulation • Potential to improve recovery in chronic inflammatory conditions Who May Benefit ARA-290 may be considered by individuals with: • Chronic inflammation and autoimmune-related conditions • Neuropathic pain or small fiber neuropathy • Tissue or vascular injury requiring improved repair response • Those seeking novel therapies for systemic recovery under medical supervision How It’s Administered • Route: Subcutaneous injection • Frequency: Typically multiple times per week, depending on protocol • Often Paired With: TB-500 for repair, or NAD+ therapy for cellular support Pricing • Initial Visit with Starting Medication: $240 - 16mg • Each Additional Vial: $140 (up to 3-month cycle) Safety and Considerations ARA-290 is considered investigational and not FDA-approved. Clinical trials suggest it is generally well-tolerated, with mild side effects such as local injection site irritation. Patients should undergo screening and be monitored throughout therapy. Please visit our medical disclaimer page for more information: https://www.skyhealthnv.com/medical-disclaimer